Market News (Page 55) - TendieTensor

Market News Page 55 of 293 • 7,305 articles

Best GLP-1 Patches and Ozempic Alternatives for 2026: Industry Analysis Examines What Herbal Wellness Patches Actually Contain as New Year Weight Management Searches Surge

GlobeNewswire Inc. • Not Specified

Best GLP-1 Patches and Ozempic Alternatives for 2026: Industry Analysis Examines What Herbal Wellness Patches Actually Contain as New Year Weight Management Searches Surge

12/29/2025 07:44 PM • An industry analysis examines the growing market for herbal wellness patches marketed as GLP-1 alternatives, clarifying that these topical products contain botanical ingredients like peony root extract and mineral oil—not pharmaceutical GLP-1 receptor agonists like semaglutide or tirzepatide. The analysis emphasizes that no FDA-approved GLP-1 patches exist, distinguishes between prescription medications and herbal wellness products, and provides consumers with evaluation frameworks for understanding product claims, company transparency, and realistic expectations for this unproven product category.

VECO - Won Corporate ORBIE Award, highlighting cybersecurity achievements
NVO - Novo Nordisk's FDA-approved GLP-1 medications (Ozempic, Wegovy) are positioned as the gold standard with 'the strongest clinical evidence base for weight management' and 'extensive clinical trials.' The article contrasts these prescription medications favorably against unproven herbal alternatives, implicitly validating their efficacy and regulatory oversight.

#GLP-1 patches #weight loss patches #herbal wellness #Ozempic alternatives #FDA regulation #consumer marketing #transdermal delivery #weight management #pharmaceutical vs herbal #product transparency

MCTA Stockholders with Large Losses Should Contact Robbins LLP for Information About Leading the Charming Medical, Limited Class Action

GlobeNewswire Inc. • Robbins Llp

MCTA Stockholders with Large Losses Should Contact Robbins LLP for Information About Leading the Charming Medical, Limited Class Action

12/29/2025 07:41 PM • Robbins LLP is investigating allegations that Charming Medical, Limited (MCTA) engaged in a fraudulent stock promotion scheme involving social media misinformation and impersonated financial professionals. The stock surged from $4.00 to $29.36 per share before the SEC halted trading on November 12, 2025. The company allegedly failed to disclose the artificial trading activity and false rumors driving the price spike.

MCTA - Company is subject to SEC trading halt and class action lawsuit alleging fraudulent stock promotion scheme, undisclosed insider share dumping, and failure to disclose material information about artificial price inflation driven by social media misinformation.

#class action lawsuit #fraudulent stock promotion #SEC trading halt #social media misinformation #securities fraud #shareholder losses

Integer Holdings Corporation Stockholders with Losses Should Contact Robbins LLP to Learn About Leading the ITGR Securities Class Action

GlobeNewswire Inc. • Robbins Llp

Integer Holdings Corporation Stockholders with Losses Should Contact Robbins LLP to Learn About Leading the ITGR Securities Class Action

12/29/2025 07:39 PM • Robbins LLP is investigating a securities class action against Integer Holdings Corporation (ITGR) for allegedly misleading investors about demand for its electrophysiology (EP) devices. The company vastly overstated EP device demand, which had actually declined significantly. On October 23, 2025, Integer cut its full-year 2025 guidance and admitted two PE devices experienced slower-than-forecasted adoption, causing the stock to plummet 32% to $73.89 per share. Shareholders with losses are eligible to participate in the class action, with a lead plaintiff deadline of February 9, 2026.

ITGR - The company is accused of misleading investors about EP device demand, which actually declined significantly. Management cut full-year guidance and admitted to slower-than-forecasted product adoption, resulting in a 32% stock price decline and triggering a securities class action lawsuit.

#securities class action #misleading investors #electrophysiology devices #demand overstatement #guidance cut #stock decline #shareholder losses

CPNG Stockholders with Large Losses Should Contact Robbins LLP for Information About Leading the Coupang, Inc. Securities Class Action

GlobeNewswire Inc. • Robbins Llp

CPNG Stockholders with Large Losses Should Contact Robbins LLP for Information About Leading the Coupang, Inc. Securities Class Action

12/29/2025 07:39 PM • Robbins LLP has filed class action lawsuits against three companies: Coupang, Inc. for failing to disclose a material cybersecurity breach involving unauthorized employee access to customer data; Charming Medical, Limited for engaging in a fraudulent stock promotion scheme; and Integer Holdings Corporation for misleading investors regarding product demand. Shareholders with significant losses are encouraged to contact the firm.

SXTPW - Mixed financial performance with revenue growth but increased losses, ongoing research and development efforts, and strategic partnerships indicate potential future opportunities
CPNG - Company failed to disclose inadequate cybersecurity protocols that allowed unauthorized access to sensitive customer data for six months and failed to report the breach in compliance with SEC rules, resulting in stock price decline and investor harm.

#class action lawsuit #cybersecurity breach #securities fraud #shareholder litigation #data breach #investor losses #regulatory violations

Why DigitalBridge Group Stock Rocked the Market Today

The Motley Fool • Eric Volkman

Why DigitalBridge Group Stock Rocked the Market Today

12/29/2025 07:36 PM • DigitalBridge Group's stock surged nearly 10% after announcing a $4 billion acquisition deal by SoftBank Group. SoftBank will pay $16 per share in cash, though the stock closed at $15.26, reflecting investor skepticism. The acquisition targets DigitalBridge's digital infrastructure business, which supplies hardware for data centers—a hot sector due to AI demand.

DBRG - Stock surged 9.66% on acquisition announcement at $16/share valuation. Company operates in strong AI data center infrastructure market with reliable profitability. Deal represents significant premium to current trading price.

#acquisition #SoftBank #DigitalBridge #data centers #AI infrastructure #buyout #$4 billion deal

Gauzy Ltd. Stockholders with Large Losses Should Contact Robbins LLP to Learn About Leading the GAUZ Securities Class Action

GlobeNewswire Inc. • Robbins Llp

Gauzy Ltd. Stockholders with Large Losses Should Contact Robbins LLP to Learn About Leading the GAUZ Securities Class Action

12/29/2025 07:33 PM • Robbins LLP filed a class action lawsuit against Gauzy Ltd. (GAUZ) alleging the company misled investors by failing to disclose that three French subsidiaries lacked financial means to meet debts, making insolvency proceedings likely. The company announced on November 14, 2025 that French insolvency proceedings had commenced, triggering a default under senior secured debt facilities. The stock price fell 49.8% following the announcement.

APP - Added $3.2 billion to buyback program, reduced share dilution, and has strong stock performance in 2025
GAUZ - Company failed to disclose material information about subsidiary insolvency risks, leading to a 49.8% stock price decline and triggering debt default. The undisclosed financial distress of three French subsidiaries represents a significant breach of investor disclosure obligations.

#class action lawsuit #securities fraud #non-disclosure #insolvency proceedings #French subsidiaries #debt default #stock price decline

Mesoblast Retires Senior Debt with Non-Dilutive, Lower Cost, Five-Year Credit Line

GlobeNewswire Inc. • Na

Mesoblast Retires Senior Debt with Non-Dilutive, Lower Cost, Five-Year Credit Line

12/29/2025 06:57 PM • Mesoblast Limited announced it has repaid its senior secured loan from Oaktree Capital Management and partially repaid its subordinated royalty facility from NovaQuest Capital Management by drawing US$75 million from a new five-year facility provided by shareholder Dr Gregory George. The company has an option to draw an additional US$50 million by June 30, 2026. The new facility features a fixed 8.00% interest rate (lower than existing debt), no early prepayment fees, and does not encumber material assets or intellectual property.

MESO - The company successfully refinanced its debt at a substantially lower interest rate (8.00% vs. higher existing rates), eliminated early prepayment penalties, freed up major assets for strategic partnerships, and secured additional capital flexibility with an option to draw up to US$50 million more. These are favorable financial developments that improve the company's capital structure and operational flexibility.

#debt refinancing #cellular medicines #financing facility #mesenchymal stromal cell therapy #Ryoncil #graft versus host disease

Sportstech Brands Holding GmbH Provides Update on Discussions with Interactive Strength, Inc. (Nasdaq: TRNR)

Benzinga • Globe Newswire

Sportstech Brands Holding GmbH Provides Update on Discussions with Interactive Strength, Inc. (Nasdaq: TRNR)

12/29/2025 06:49 PM • Sportstech Brands Holding GmbH announced that acquisition negotiations with Interactive Strength, Inc. (NASDAQ: TRNR) have been suspended as of November 27, 2025, due to inability to agree on key economic and strategic terms. The planned U.S. market entry will not proceed as originally intended. However, Sportstech reported strong 2025 business performance and expects further improvement in 2026.

ORCL - Rationing customers due to infrastructure delays, but still maintains large market cap and backlog
TRNR - The failed acquisition deal represents a loss of strategic opportunity for market expansion and growth. The inability to reach agreement on key terms suggests potential challenges in valuation or strategic alignment.

#acquisition #negotiations suspended #U.S. market entry #home fitness #strategic terms

Sportstech Brands Holding GmbH informiert über den aktuellen Stand der Gespräche mit Interactive Strength, Inc. (Nasdaq: TRNR)

GlobeNewswire Inc. • Sportstech Brands Holding Gmbh

Sportstech Brands Holding GmbH informiert über den aktuellen Stand der Gespräche mit Interactive Strength, Inc. (Nasdaq: TRNR)

12/29/2025 06:49 PM • Sportstech Brands Holding GmbH has suspended acquisition negotiations with Interactive Strength, Inc. (Nasdaq: TRNR) that began in late 2024, citing inability to agree on key economic and strategic terms. The parties reached no mutual basis to proceed toward a binding agreement as of November 27, 2025. Sportstech's planned US market entry, which was integral to the acquisition strategy, is now postponed. However, the company reports strong 2025 performance and expects further operational improvements in 2026, positioning it for a potential later US market entry.

QQQ - Down 2.9% in November, on pace for worst performance since 2008
TRNR - The failed acquisition represents a lost strategic opportunity for Interactive Strength to expand through acquiring Sportstech. The breakdown in negotiations suggests the deal did not meet the company's expectations or requirements.

#acquisition #merger negotiations #US market entry #home fitness #strategic partnership

GlobeNewswire Inc. • Na

Sportstech Brands Holding GmbH Provides Update on Discussions with Interactive Strength, Inc. (Nasdaq: TRNR)

12/29/2025 06:49 PM • Sportstech Brands Holding GmbH announced that negotiations with Interactive Strength, Inc. (NASDAQ: TRNR) regarding a potential acquisition have been suspended as of November 27, 2025, due to inability to agree on key economic and strategic terms. The company has postponed its planned U.S. market entry but remains optimistic about strong 2025 performance and future growth prospects.

GEV - Sold out equipment pipeline through 2028, indicating strong demand but potential capacity constraints
TRNR - The failed acquisition negotiations represent a lost growth opportunity and strategic setback. The inability to reach agreement on key terms and suspension of discussions indicates a negative outcome for the company's expansion plans.

#acquisition #negotiations suspended #U.S. market entry #home fitness #strategic terms

Meridianbet (GMGI) Extends Title Sponsorship with EuroLeague's Crvena Zvezda Through 2030

GlobeNewswire Inc. • Na

Meridianbet (GMGI) Extends Title Sponsorship with EuroLeague's Crvena Zvezda Through 2030

12/29/2025 06:37 PM • Meridianbet, a subsidiary of Golden Matrix Group Inc. (NASDAQ: GMGI), has extended its title sponsorship with BC Crvena Zvezda (Red Star Belgrade) through 2030. The multi-year extension builds on a successful three-year partnership established in 2023, with the club continuing to compete as 'Crvena Zvezda Meridianbet' across EuroLeague and other competitions. The renewed agreement includes increased financial commitment and enhanced brand activation initiatives.

GMGI - The company's subsidiary Meridianbet is extending a major European sports sponsorship through 2030 with increased financial commitment and brand activation, demonstrating confidence in long-term market expansion across 18 jurisdictions and strategic investment in premium sports properties with significant global reach.

#sports betting #iGaming #title sponsorship #EuroLeague #basketball #brand partnership #long-term commitment #European markets

Kessler Topaz Meltzer & Check, LLP Encourages Bitdeer Technologies Group Investors with Losses to Contact the Firm

GlobeNewswire Inc. • Kessler Topaz Meltzer & Check, Llp

Kessler Topaz Meltzer & Check, LLP Encourages Bitdeer Technologies Group Investors with Losses to Contact the Firm

12/29/2025 06:32 PM • A securities class action lawsuit has been filed against Bitdeer Technologies Group (NASDAQ: BTDR) for allegedly making materially false and misleading statements regarding its SEAL04 chip design progress and production timeline. The lawsuit covers investors who purchased Bitdeer securities between June 6, 2024, and November 10, 2025. The lead plaintiff deadline is February 2, 2026.

BTDR - The company is accused of making materially false and misleading statements about its SEAL04 chip design progress and production timeline. Defendants allegedly concealed design issues and delays while reassuring the public that operations were on track, resulting in a securities class action lawsuit.

#class action lawsuit #securities fraud #SEAL04 chip #misleading statements #production delay #dual-track approach

California Water Service Receives Approval for Interim Rate Adjustments from California Public Utilities Commission

GlobeNewswire Inc. • Not Specified

California Water Service Receives Approval for Interim Rate Adjustments from California Public Utilities Commission

12/29/2025 06:00 PM • California Water Service has received CPUC approval to implement interim rate adjustments of 3% for most service areas effective January 1, 2026, while the utility's 2024 General Rate Case continues under review. The interim rates will help the company continue infrastructure investments and mitigate the impact of delayed rate case decisions on customers.

SHNY - Proposed a modular approach to AI agents, focusing on specialized, discrete task performance
CWT - The company received regulatory approval for interim rate adjustments that will enable continued infrastructure investments and help mitigate negative impacts from delayed rate case decisions. The approval supports the company's operational and financial objectives while addressing customer affordability concerns.

#interim rate adjustments #CPUC approval #General Rate Case #infrastructure investment #water utility #rate increase #California

Unlimited ETFs to Transfer Exchange Listings to New York Stock Exchange

GlobeNewswire Inc. • Na

Unlimited ETFs to Transfer Exchange Listings to New York Stock Exchange

12/29/2025 05:58 PM • Unlimited ETFs announced that its HFMF Managed Futures ETF and HFEQ Equity Long/Short ETF will transfer listings from NYSE Arca to the New York Stock Exchange effective January 2, 2026. The move aims to enhance market quality and visibility through designated market maker support, with no changes to fund strategies or objectives.

WTID - Proposed a modular approach to AI agents, focusing on specialized, discrete task performance
HFMF - The ETF benefits from the transfer to NYSE with designated market maker support, which should improve liquidity and trading conditions for investors.

#ETF listing transfer #NYSE #hedge fund replication #HFMF #HFEQ #designated market maker #market quality

Stock Market Today, Dec. 29: DigitalBridge Group Surges on Deal With SoftBank to Acquire the Company for $4 Billion

The Motley Fool • Josh Kohn-Lindquist

Stock Market Today, Dec. 29: DigitalBridge Group Surges on Deal With SoftBank to Acquire the Company for $4 Billion

12/29/2025 05:32 PM • SoftBank announced an agreement to acquire DigitalBridge Group for $16 per share in cash, valuing the digital infrastructure company at $4 billion. DigitalBridge's stock surged 9.63% on the news, though some analysts have issued higher price targets of $20-$23, raising questions about whether shareholders will accept the offer. The deal reflects SoftBank's strategy to build digital infrastructure to support AI growth.

WTIU - Proposed a modular approach to AI agents, focusing on specialized, discrete task performance
DBRG - Stock surged 9.63% on acquisition announcement at $16/share; however, sentiment is tempered by existing analyst price targets of $20-$23, suggesting the offer may be undervalued and shareholders may reject it.

#acquisition #digital infrastructure #data centers #AI growth #SoftBank #DigitalBridge #merger

Kandal M Venture Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

GlobeNewswire Inc. • Na

Kandal M Venture Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

12/29/2025 05:00 PM • Kandal M Venture Limited (FMFC), a Cambodia-based contract manufacturer of leather goods, received a Nasdaq noncompliance notice for failing to maintain the minimum $1 per share bid price requirement. The company has 180 calendar days to regain compliance, with the possibility of an additional 180-day period if it meets other listing standards. The stock will continue trading under the symbol FMFC during this period.

JETD - Proposed a modular approach to AI agents, focusing on specialized, discrete task performance
FMFC - The company received a Nasdaq noncompliance notice for failing to meet minimum bid price requirements, creating delisting risk. While the company has 180 days to cure the deficiency and shares will continue trading, this is a significant regulatory warning that indicates financial distress and stock price weakness.

#Nasdaq listing requirement #minimum bid price deficiency #compliance period #delisting risk #leather goods manufacturer #Cambodia

Credicorp Ltd.: Banco de Crédito del Perú to acquire 100% of Helm Bank USA

GlobeNewswire Inc. • Na

Credicorp Ltd.: Banco de Crédito del Perú to acquire 100% of Helm Bank USA

12/29/2025 04:54 PM • Credicorp Ltd.'s subsidiary Banco de Crédito del Perú (BCP) has agreed to acquire 100% of Helm Bank USA for USD 180 million. The acquisition aims to enhance Credicorp's cross-border capabilities and better serve Latin American clients with financial needs spanning both their home countries and the United States. Helm Bank, a Florida-based community bank with USD 1.1 billion in assets, will maintain its community-focused legacy under Credicorp's ownership. The transaction is subject to regulatory approvals in the United States and Peru.

JETU - Proposed a modular approach to AI agents, focusing on specialized, discrete task performance
BAP - The acquisition demonstrates strategic expansion into the U.S. market and strengthens Credicorp's ability to serve internationally active Latin American clients. Leadership expresses confidence in the strategic fit and growth potential, indicating positive momentum for the company's cross-border capabilities.

#acquisition #cross-border banking #Latin America #community bank #financial services #regulatory approval

TLX 11-DAY DEADLINE ALERT: Hagens Berman Urges Telix (TLX) Investors to Act by Jan. 9 Over Alleged Dual Regulatory Failures: SEC Subpoena & FDA CRL on CMC/Supply Chain

GlobeNewswire Inc. • Hagens Berman

TLX 11-DAY DEADLINE ALERT: Hagens Berman Urges Telix (TLX) Investors to Act by Jan. 9 Over Alleged Dual Regulatory Failures: SEC Subpoena & FDA CRL on CMC/Supply Chain

12/29/2025 04:48 PM • Hagens Berman is urging Telix Pharmaceuticals investors to act by January 9, 2026, as lead plaintiff deadline approaches in a securities class action lawsuit. The lawsuit alleges the company materially overstated therapeutic candidate progress and concealed supply chain/manufacturing deficiencies. Regulatory setbacks include an SEC subpoena regarding drug development disclosures and an FDA Complete Response Letter rejecting the Zircaix application due to Chemistry, Manufacturing, and Controls deficiencies, triggering a 21% stock decline.

NRGD - Proposed a modular approach to AI agents, focusing on specialized, discrete task performance
TLX - Company faces dual regulatory investigations (SEC subpoena and FDA CRL), alleged material misstatements about drug development progress, concealed supply chain deficiencies, and significant stock decline (21% drop), resulting in securities fraud litigation and investor losses.

#securities class action #regulatory failure #SEC subpoena #FDA Complete Response Letter #CMC deficiencies #supply chain #manufacturing #investor losses #lead plaintiff deadline

Applied Digital to Spin Out Cloud Business, Proposes Business Combination with EKSO to Launch ChronoScale

GlobeNewswire Inc. • Na

Applied Digital to Spin Out Cloud Business, Proposes Business Combination with EKSO to Launch ChronoScale

12/29/2025 04:45 PM • Applied Digital announced a proposed business combination of its cloud computing division (Applied Digital Cloud) with EKSO Bionics to create ChronoScale, a GPU-accelerated compute platform purpose-built for AI workloads. Applied Digital would own approximately 97% of the combined company post-closing. The transaction is expected to close in H1 2026 and aims to allow each business to scale independently with greater strategic flexibility.

OILD - Proposed a modular approach to AI agents, focusing on specialized, discrete task performance
APLD - The company is strategically separating its cloud business to create a focused, specialized AI compute platform (ChronoScale) with greater capital flexibility. Applied Digital Cloud generated $75.2M in revenue (12-month period ending Aug 31, 2025) with strong growth, and Applied Digital retains 97% ownership of the combined entity, maintaining significant value and control.

#business combination #GPU infrastructure #AI workloads #cloud computing #accelerated compute platform #spinout #ChronoScale

Benzinga • Globe Newswire

Applied Digital to Spin Out Cloud Business, Proposes Business Combination with EKSO to Launch ChronoScale

12/29/2025 04:45 PM • Applied Digital announced a proposed business combination of its cloud computing business with Ekso Bionics Holdings to create ChronoScale, an accelerated compute platform for AI workloads. Applied Digital would own approximately 97% of the combined company upon closing. The transaction is expected to close in the first half of 2026, allowing each business to scale independently with greater strategic flexibility.

NRGU - Proposed a modular approach to AI agents, focusing on specialized, discrete task performance
APLD - The company is strategically spinning out its cloud business to create a focused, high-growth AI compute platform (ChronoScale) while maintaining 97% ownership. This allows independent scaling and greater capital flexibility. The cloud business generated $75.2M in revenue (12-month period ending August 31, 2025) with strong demand from enterprise and AI customers.

#business combination #cloud computing #AI infrastructure #GPU acceleration #data centers #spinout #ChronoScale

Royalty Pharma Acquires Remaining Royalty Interest in Roche's Evrysdi for $240 Million and Potential Milestones

Benzinga • Globe Newswire

Royalty Pharma Acquires Remaining Royalty Interest in Roche's Evrysdi for $240 Million and Potential Milestones

12/29/2025 04:40 PM • Royalty Pharma has acquired the final portion of PTC Therapeutics' remaining royalty on Roche's Evrysdi for $240 million upfront plus up to $60 million in sales-based milestones. Following the transaction, Royalty Pharma will own 100% of the tiered 8% to 16% royalty on worldwide net sales of Evrysdi, an FDA-approved spinal muscular atrophy treatment that generated approximately $1.9 billion in sales in 2024 with projected growth to $2.9 billion by 2030.

OILU - Proposed a modular approach to AI agents, focusing on specialized, discrete task performance
RPRX - Acquisition of full royalty ownership on a high-growth commercial product (Evrysdi) with strong sales trajectory ($1.9B in 2024, projected $2.9B by 2030) and 18% YoY growth. This consolidates Royalty Pharma's position in a profitable revenue stream with tiered royalty rates up to 16%.

#royalty acquisition #Evrysdi #spinal muscular atrophy #biopharmaceutical royalties #sales-based milestones

ASML Holds Premium Valuation as Semiconductor Capex Momentum Carries Into 2026

Investing.com • Itai Smidt

ASML Holds Premium Valuation as Semiconductor Capex Momentum Carries Into 2026

12/29/2025 03:51 PM • ASML trades at $1,066 with a 37.4x P/E multiple, justified by its near-monopoly in EUV lithography and strong semiconductor capex growth expected through 2026. While China revenue normalization poses a near-term headwind, core customers like TSMC, SK hynix, and Micron are projected to grow capex 18-19% in 2026, supporting mid-single-digit to low double-digit revenue growth. The stock deserves a Buy rating with 16-17% upside to fair value over 12-24 months.

GDXU - Proposed a modular approach to AI agents, focusing on specialized, discrete task performance
ASML - ASML maintains a strong competitive moat with its near-monopoly in advanced EUV and High-NA lithography systems. Despite a premium 37.4x P/E valuation, the company is supported by robust semiconductor capex growth (11-19% for core customers in 2026), high FCF margins (27.7%), and limited competitive threats. The stock offers 16-17% upside to fair value with manageable risks.

#ASML #semiconductor equipment #EUV lithography #capex cycle #High-NA EUV #China export restrictions #AI infrastructure spending #TSMC #Samsung #Intel #Micron #SK hynix

GlobeNewswire Inc. • Na

Changes in company's own shares

12/29/2025 02:40 PM • Alvotech announced the European launch of AVT05, its first-in-market biosimilar to Simponi (golimumab), in partnership with Advanz Pharma. The launch is supported by an NHS England tender award in the United Kingdom. The company also published its 2026 financial calendar.

FNGU - Proposed a modular approach to AI agents, focusing on specialized, discrete task performance
ALVO - Company achieved a significant milestone with the European launch of its first-in-market biosimilar, supported by NHS England tender award, indicating market validation and commercial progress.

#biosimilar #AVT05 #Simponi #golimumab #European launch #NHS England #Advanz Pharma #financial calendar

GlobeNewswire Inc. • Na

Breyting á fjölda eigin hluta

12/29/2025 02:40 PM • Alvotech announced the European launch of AVT05, its first-in-market biosimilar to Simponi (golimumab), through partner Advanz Pharma. The launch is supported by an NHS England tender award in the United Kingdom. The company also published its financial calendar for 2026.

FNGS - Proposed a modular approach to AI agents, focusing on specialized, discrete task performance
ALVO - The company achieved a significant milestone with the European launch of its first-in-market biosimilar, supported by an NHS England tender award, which validates market demand and provides competitive advantage in the biosimilar space.

#biosimilar #AVT05 #Simponi #golimumab #European launch #NHS England #Advanz Pharma

This Energy Stock Fell 11% in a Year, but One Fund Is Betting $169 Million on Its Performance

The Motley Fool • Jonathan Ponciano

This Energy Stock Fell 11% in a Year, but One Fund Is Betting $169 Million on Its Performance

12/29/2025 02:30 PM • Denver-based Sourcerock Group significantly increased its stake in California Resources Corporation (CRC) by 1.18 million shares in Q3, bringing its total holding to 3.18 million shares valued at $169.14 million. Despite CRC's 11% decline over the past year, the fund's conviction bet reflects confidence in the company's strong cash flow generation, with Q3 operating cash flow of $279 million and a 5% dividend increase, positioning it as a resilient energy play for patient capital.

GDXD - Proposed a modular approach to AI agents, focusing on specialized, discrete task performance
CRC - Despite a 11% stock price decline over the past year, the company demonstrates strong fundamentals with $279 million in Q3 operating cash flow, $188 million in free cash flow, a 5% dividend increase, and $1.15 billion in liquidity. A major institutional fund's $169 million investment increase signals confidence in its cash generation and resilience, positioning it as a valuable long-term holding for patient investors seeking cash flow stability in the energy sector.

#California Resources Corporation #energy stock #institutional investment #cash flow #dividend #oil and gas #Sourcerock Group